Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
278.25 USD | +0.70% |
|
+0.39% | +18.25% |
Consensus | 4m Target Price Revision | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
US$299.74 | +8.48% | 30 | |||||||
US$975.09 | +15.78% | 26 | |||||||
DKK 828.63 | +33.76% | 24 | |||||||
US$168.64 | +9.02% | 21 | |||||||
US$204.9 | +6.86% | 27 | |||||||
CHF 307.08 | +5.42% | 19 | |||||||
US$119.34 | +33.09% | 24 | |||||||
CHF 114.7 | +4.82% | 20 | |||||||
GBX 172.84 | +24.09% | 19 | |||||||
US$314.28 | +2.1% | 26 | |||||||
US$30.95 | +17.05% | 22 | |||||||
€116.62 | +12.57% | 22 | |||||||
US$101.24 | +1.59% | 25 | |||||||
US$61.72 | +3.37% | 21 | |||||||
GBX 17.99 | +21.15% | 19 | |||||||
JP¥7,510 | +13.36% | 15 | |||||||
JP¥6,216.67 | +57.98% | 18 | |||||||
GBX 3.993 | +5.52% | 17 | |||||||
JP¥4,777.35 | +16.66% | 17 | |||||||
Average | 1,175.88 | +15.40% | 22 | ||||||
Weighted average by Cap. | 662.37 | +15.22% | 23 |
- Stock Market
- Equities
- ALNY Stock
- Sector Alnylam Pharmaceuticals, Inc.
- Sector consensus

MarketScreener is also available in this country: United States.
Switch edition